Download in electronic PDF format for $25



Search the Complete Journal Archives

Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures

Author(s):  Nahata Milap C

Issue:  Mar/Apr 2016 - Volume 20, Number 2
View All Articles in Issue

Abstract:  The lack of commercially available liquid dosage forms for pediatric patients prompted this study. The objectives of our study were to determine the stability of zonisamide, amitriptyline, and glycopyrrolate in extemporaneously prepared oral suspensions in plastic prescription bottles. One group of suspensions was prepared in OraPlus:OraSweet (1:1) for each drug and stored either under refrigeration (4°C) or at room temperature (25°C). A second group of suspensions were compounded in 1% methylcellulose:simple syrup at a 1:10 proportion for zonisamide, amitriptyline, and glycopyrrolate; these suspensions were stored at either under refrigeration (4°C) or at room temperature (25°C). The drug concentrations were measured by the stability-indicating high-performance liquid chromatographic methods. The mean concentration of zonisamide (10 mg/mL) remained above 95% of the original concentration for 91 days in each group of suspensions at both 4°C and 25°C. The mean concentration of amitriptyline (20 mg/mL) was above 95% for 91 days in the suspensions containing OraPlus/OraSweet at both 4°C and 25°C. However, in the suspensions containing methylcellulose:simple syrup, the mean concentration of amitriptyline was about 95% for 42 days at 4°C and 28 days at 25°C. The mean concentration of glycopyrrolate (0.2 mg/mL) was above 95% in each group of suspensions during the 14-day study period. These data indicate that zonisamide, amitriptyline, and glycopyrrolate can be prepared extemporaneously as suspensions and stored in plastic prescription bottles for varying periods at 4°C and 25°C for use in pediatric patients.

Related Keywords: Milap C. Nahata, PharmD, MS, zonisamide, amitriptyline, glycopyrrolate, anticonvulsant agent, seizure disorder, depression, depressive disorder, tricyclic antidepressant, neuropathy, neuropathic pain, neuralgia, anticholinergic agent, acetylcholine, secretions, gastrointestinal ulcers, sweating, perspiration, hyperhidrosis, oral suspensions, liquid suspending vehicles, liquid dosage forms

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS, STORAGE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Nahata Milap C Mar/Apr 2016 164-166 Buy
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III May/Jun 2010 182-192 Buy
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A Jan/Feb 2003 10 View Sample
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L May/Jun 2010 200-203 Buy
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr Mar/Apr 2011 157 Buy
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph Mar/Apr 2016 107-113 Buy
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium Jones Marty Jan/Feb 2000 6 Buy
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Jones Marty Jan/Feb 2002 4 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy